Lipum AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
Oct 23Expected
Q2 2025
Q3 2025
-0.84
-0.61
-0.39
-0.16
Expected EPS
-0.1604492032
Actual EPS
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company develops SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. It has a collaboration with NorthXBiologies for production of SOL-116 setatt; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.
Show More
CEO
Prof. Olle Hernell M.D.
Employees
5
Country
Sweden
ISIN
SE0021922598
Listings
0 Comments
Share your thoughts
FAQs
What is Lipum AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Lipum AB stocks are traded under the ticker LIPUM-BTA.ST.
How many employees does Lipum AB have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Lipum AB located?▼
Lipum AB operates in the Health & Wellness sector.
When did Lipum AB complete a stock split?▼
Lipum AB has not had any recent stock splits.
Where is Lipum AB headquartered?▼
Lipum AB is headquartered in Umeå, Sweden.